Who owns ARWR? 13F holders and whale ownership
ARWR is tracked across public portfolios in Whale Analyzer. This page answers who owns ARWR, which top funds are buying ARWR, aggregate disclosed value, and recent position changes based on public data. Baker Bros. Advisors is the largest reported holder at $125M; the top five funds control 100.0% of reported ownership; institutions were net selling last quarter (0 increased, 1 reduced); the stock trades above the aggregate whale cost basis of $16.48. Top tracked holders include Baker Bros. Advisors and Edgewood Management.
Continue to the live ARWR dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Baker Bros. Advisors 13F portfolio Baker Bros. Advisors holdings | $124.9M | 2.0M | Reduced |
| Edgewood Management 13F portfolio Edgewood Management LLC holdings | $1.6M | 25.0K | Held |
Ownership concentration
Reported ownership of ARWR is highly concentrated across tracked institutions.
- Single largest holder: 98.8% of reported ownership
- Top 5 holders: 100.0%
- Top 10 holders: 100.0%
Whale activity this quarter
Across 2 tracked institutions, 1 reduced, 1 held. Net positioning is net selling.
- Baker Bros. Advisors — Baker Bros. Advisors ($124.9M) (▼ 8.4% qoq shares) · avg cost $16.56
- Edgewood Management — Edgewood Management LLC ($1.6M) (→ 0.0% qoq shares) · avg cost $10.56
Whale cost basis vs current price
The aggregate tracked cost basis is $16.48 versus a current price of $78.89, so ARWR trades above its cost basis (+378.6%). Average unrealized P&L across tracked holders: 498%.
Sector positioning — Health Care
ARWR sits within the Health Care sector alongside 221 other tracked names. Compare whale ownership across peers:
How to use this page
Values are reported public positions from tracked 13F filers and disclosures — not real-time ownership totals. Open the live ARWR dashboard for price charts and cross-investor scans, or read the SEC 13F guide.
Related stock holder pages
- INCY whale holders — Incyte Corporation
- BEIGF whale holders — BeOne Medicines Ltd.
- INSM whale holders — Insmed Incorporated
- MDGL whale holders — Madrigal Pharmaceuticals, Inc.
- ACAD whale holders — ACADIA Pharmaceuticals Inc.
- RVMDW whale holders — Revolution Medicines, Inc.
- CELC whale holders — Celcuity Inc.
- KOD whale holders — Kodiak Sciences Inc.
Learn more in Whale Analyzer Academy
Deepen your read on ARWR with these Whale Analyzer Academy guides:
Frequently asked questions
Who owns ARWR stock?
Whale Analyzer tracks 2 public institutional holders of ARWR with a combined reported value of $126.5M. See the holder table above for the largest tracked positions.
Which top funds are buying ARWR?
Tracked institutions were net selling last quarter — 1 reduced, 1 held. Check the "Change" column: "New" = fresh position, "Increased" = added, "Reduced" = trimmed.
How concentrated is ARWR ownership?
The top five tracked holders report 100.0% of aggregate ownership.
Is ARWR above or below the whale cost basis?
The aggregate tracked cost basis is $16.48 versus a current price of $78.89 (+378.6%).
What does 13F ownership mean for ARWR?
Use the interactive ARWR dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.